A novel post-transcriptional role for ubiquitin in the differential regulation of MHC class I allotypes

Molecular Immunology

Volumn 55, Issue 2, 2013, Pages 135-138

  Cano, Florencia ^a   Lehner, Paul J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

3' UTR; Antigen presentation; HLA A; MHC class I; MRNA decay; NK cells; Ubiquitin; Ubiquitin E3 ligase

Indexed keywords

HLA A ANTIGEN; HLA A2 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3;

3' UNTRANSLATED REGION; ADAPTIVE IMMUNITY; ALLOTYPE; BINDING KINETICS; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; INNATE IMMUNITY; MOLECULAR RECOGNITION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; REVIEW; TARGET CELL; TRANSCRIPTION REGULATION; UPREGULATION;

HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN ALLOTYPES; KILLER CELLS, NATURAL; PROTEIN STRUCTURE, TERTIARY; RNA INTERFERENCE; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; UBIQUITIN;

EID: 84875631118     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.10.015     Document Type: Review

References (24)

1. Blais M.E., Dong T., Rowland-Jones S. HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?. Immunology 2011, 133:1-7.
2. Browne S.K., Roesser J.R., Zhu S.Z., Ginder G.D. Differential IFN-gamma stimulation of HLA-A gene expression through CRM-1-dependent nuclear RNA export. Journal of Immunology 2006, 177:8612-8619.
3. Buchet-Poyau K., Courchet J., Le Hir H., Séraphin B., Scoazec J.Y., Duret L., Domon-Dell C., Freund J.N., Billaud M. Identification and characterization of human Mex-3 proteins, a novel family of evolutionarily conserved RNA-binding proteins differentially localized to processing bodies. Nucleic Acids Research 2007, 35:1289-1300.
4. Cano F., Miranda-Saavedra D., Lehner P.J. RNA-binding E3 ubiquitin ligases: novel players in nucleic acid regulation. Biochemical Society Transactions 2010, 38:1621-1626.
5. Cano F., Bye H., Duncan L.M., Buchet-Poyau K., Billaud M., Wills M.R., Lehner P.J. The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradation. EMBO Journal 2012, 31:3596-3606.
6. Chalifour A., Scarpellino L., Back J., Brodin P., Devèvre E., Gros F., Lévy F., Leclercq G., Höglund P., Beermann F., Held W. A role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 2009, 30:337-347.
7. Doucey M.A., Scarpellino L., Zimmer J., Guillaume P., Luescher I.F., Bron C., Held W. Cis-association of Ly49A with MHC class I restricts natural killer cell inhibition. Nature Immunology 2004, 5:328-336.
8. Draper B.W., Mello C.C., Bowerman B., Hardin J., Priess J.R. MEX-3 is a KH domain protein that regulates blastomere identity in early C. elegans embryos. Cell 1996, 87:205-216.
9. Ferrone S., Marincola F.M. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunology Today 1995, 16:487-494.
10. Held W., Mariuzza R.A. Cis interactions of immunoreceptors with MHC and non-MHC ligands. Nature Reviews Immunology 2008, 8:269-278.
11. Hunter C.P., Kenyon C. Spatial and temporal controls target pal-1 blastomere-specification activity to a single blastomere lineage in C. elegans embryos. Cell 1996, 87:217-226.
12. Johnson D.R. Locus-specific constitutive and cytokine-induced HLA class I gene expression. Journal of Immunology 2003, 170:1894-1902.
13. Kageshita T., Wang Z., Calorini L., Yoshii A., Kimura T., Ono T., Gattoni-Celli S., Ferrone S. Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens. Cancer Research 1993, 53:3349-3354.
14. Kiepiela P., Leslie A.J., Honeyborne I., Ramduth D., Thobakgale C., Chetty S., Rathnavalu P., Moore C., Pfafferott K.J., Hilton L., Zimbwa P., et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004, 432:769-775.
15. Kuchtey J., Chefalo P.J., Gray R.C., Ramachandra L., Harding C.V. Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA. Journal of Immunology 2005, 175:2244-2251.
16. Kulkarni S., Savan R., Qi Y., Gao X., Yuki Y., Bass S.E., Martin M.P., Hunt P., Deeks S.G., Telenti A., et al. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 2011, 472:495-498.
17. Masuda A., Nakamura A., Maeda T., Sakamoto Y., Takai T. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. Journal of Experimental Medicine 2007, 204:907-920.
18. McCutcheon J.A., Gumperz J., Smith K.D., Lutz C.T., Parham P. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. Journal of Experimental Medicine 1995, 181:2085-2095.
19. Mühlemann O., Lykke-Andersen J. How and where are nonsense mRNAs degraded in mammalian cells?. RNA Biology 2010, 7:28-32.
20. Shatz C.J. MHC class I: an unexpected role in neuronal plasticity. Neuron 2009, 64:40-45.
21. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nature Reviews Immunology 2005, 5:201-214.
22. van den Elsen P.J., Holling T.M., Kuipers H.F., van der Stoep N. Transcriptional regulation of antigen presentation. Current Opinion in Immunology 2004, 16:67-75.
23. Wearsch P.A., Cresswell P. The quality control of MHC class I peptide loading. Current Opinion in Cell Biology 2008, 20:624-631.
24. Willcox B.E., Thomas L.M., Bjorkman P.J. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nature Immunology 2003, 4:913-919.